Trial intelligence / Profile preview

RN-0001 for prevention of acute kidney injury after cardiopulmonary bypass cardiac surgery

ChiCTR2500107800Phase 2Completed

Sponsor
Fuwai Hospital
Start
Aug 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in acute kidney failure (AKF) comparing RN-0001 with Placebo (2 arms). Primary endpoint: Serum creatinine (SCr). Started Aug 2025; status: completed.

02

Drugs

RN-0001
03

Conditions

acute kidney failure (AKF)

Beyond the preview

Go deeper on ChiCTR2500107800.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500107800.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call